Global Acne Treatment Market Growth, Key Players, and Future Outlook
The global acne treatment market is projected to expand from USD 9,615.6 million in 2022 to approximately USD 15,183.2 million by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2032. This growth is primarily driven by increasing clinical approvals and the launch of innovative products aimed at effectively treating acne.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5037
Dermatology Clinics Fueling Acne Treatment Market Growth
Dermatology clinics are playing a key role in driving the expansion of the acne treatment market. These specialized clinics offer comprehensive care for various skin issues, including acne. They provide a variety of treatment options, ranging from medications and therapies to cosmetic procedures, all tailored to address acne concerns.
In addition, dermatology clinics are investing in cutting-edge technologies and treatments to enhance the effectiveness of acne care. Many now utilize advanced tools like laser therapy and photodynamic therapy, which have been proven to reduce acne lesions and improve the overall appearance of the skin.
Recent Developments in the Acne Treatment Market Company Announcements
In May 2023, Bausch Health Companies Inc. and its dermatology subsidiary, Ortho Dermatologics, revealed that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for IDP-126, a treatment currently under investigation. This marks a significant step forward for the company in advancing acne treatment options.
In July 2022, Glenmark Pharmaceuticals introduced MINYM, a topical Minocycline 4% Gel for the treatment of moderate to severe acne. Minocycline is a potent antibacterial gel with notable anti-inflammatory effects, and it is distinguished by having the lowest MIC90 compared to other topical antibacterial formulations.
In March 2022, Galderma launched Twyneo cream in the U.S., a topical treatment for acne vulgaris in patients aged 9 years or older. Twyneo is a fixed-dose combination of benzoyl peroxide (3%) and tretinoin (0.1%), offering a dual-action solution for acne care.
In November 2021, Sun Pharmaceutical Industries introduced Winlevi cream in the U.S. market for the treatment of acne vulgaris. Winlevi had previously received FDA approval in August 2020 and has since become a recognized acne treatment.
In June 2020, Thayer expanded its product offerings with a new acne-tailored skincare line, catering to the specific needs of individuals battling acne, providing targeted solutions for skincare and acne management.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/acne-treatment-market
Access exclusive insight now @ https://www.towardshealthcare.com/price/5037
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
